XML 53 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Sales by Product Categories

The Company’s sales by product categories for the years ended December 31, 2024 and 2023 are as follows (in thousands):

 

 

Year ended December 31,

 

 

 

2024

2023

 

Sales of Pharmaceutical Products

 

$

105,757

 

 

$

113,450

 

Total

 

$

105,757

 

 

$

113,450